Harrison.ai vs Lunit
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Harrison.ai
Australian AI that reads 124+ chest X-ray findings in under a minute
Visit
|
Lunit
KOSDAQ-listed Korean AI for breast and lung cancer screening
Visit
|
|
|---|---|---|
| RECATOOLS Score | 8.2 / 10 | 6.7 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Enterprise | Enterprise |
| Free tier | Harrison.Rad 1.5 available free for research at chat.harrison.ai | — |
| Paid from | Enterprise SaaS contracts; Open Platform charges for compute and support only | — |
| Has API | ✓ | ✗ |
| Open source | ✗ | ✗ |
| Free to use | ✗ | ✗ |
| Users | 3,400+ clinicians at 1,000+ sites across 40+ countries | — |
| Founded | 2018 | 2013 |
| Maker | Harrison.ai (independent; Sonic Healthcare holds 18% stake via Franklin.ai JV) | — |
| Verdict | Harrison.ai is one of the most clinically validated medical imaging AI platforms globally, backed by peer-reviewed publications in The Lancet Digital Health and European Radiology, 12 FDA clearances, three FDA Breakthrou... |
Lunit is the most clinically validated medical-AI company to come out of Korea, and one of the few in the category with real revenue rather than just pilot deployments — Q1 2026 revenue hit 24 billion won, up nearly 25%... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.